Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis
Yukihisa Fujinaga et al, 2020, International Journal of Molecular Sciences CrossRef